CHAI&ampampRHSC：2024年全球计生用品市场报告（英文版）（59页）.pdf

1、Family Planning Market ReportNOVEMBER 2024CONTENTSACKNOWLEDGEMENTS 3ACRONYMS 4INTRODUCTION 510 YEARS OF MARKET INTELLIGENCE IN FAMILY PLANNING 7THE STATE OF FAMILY PLANNING IN 2023 8SUPPLIER SHIPMENT ANALYSIS 9UNFPA&USAID PROCUREMENT VALUE ANALYSIS 23DOMESTIC GOVERNMENT SPEND ANALYSIS 25HIGHLIGHTS F

2、ROM DISCUSSIONS WITH KEY STAKEHOLDERS 30ABOUT THE PARTICIPATING SUPPLIERS 32APPENDICES 343ACKNOWLEDGEMENTS1 Injeflex is a new supplier participating in this years report.Refer to page 32 for more information on Injeflex and other participating suppliers.2 Established in 2020 under the RHSC,the VAN C

3、PG collaborates at the global level to address family planning commodity stock imbalances while also planning to prevent those imbalances from occurring at all.Additional information available at:https:/www.rhsupplies.org/uploads/tx_rhscpublications/CPG_2020_FINAL.pdf The Clinton Health Access Initi

4、ative(CHAI)and the Reproductive Health Supplies Coalition(RHSC)published the first Family Planning Market Report in 2015 as part of the FP2020 Global Markets Visibility Project.It initially covered 69 FP2020 focus countries.In 2021,it expanded under the FP2030 global partnership and measurement stru

5、cture to include all low-and lower-middle income countries,and now reports on 85 countries.Whereas the 2015 report featured data from 11 manufacturers,the 2024 edition has 18 participating suppliers.Suppliers shipment data is the foundation of this reports analyses,allowing CHAI and RHSC to address

6、information gaps and construct a comprehensive view of the reproductive health commodities market.We would like to thank current participating suppliers:Bayer,Cipla,Corporate Channels,CR Zizhu,Cupid,Female Health Company,Incepta,Injeflex,1 Medicines360,Organon&Co.,Pfizer,Pregna,PT Tunggal,Renata,Sen